UWA-101 is a phenethylamine derivative invented at the University of Western Australia and researched as a potential treatment for Parkinson’s disease. Its chemical structure is very similar to that of the illegal drug MDMA the only difference being the replacement of the α-methyl group with an α-cyclopropyl group.
This page contains content from the copyrighted Wikipedia article "UWA-101"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
